{"id":153528,"title":"NACI literature review on the effects of palivizumab prophylaxis on reducing the complications associated with respiratory syncytial virus in infants - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T12:20:46.602000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/effects-palivizumab-prophylaxis-reducing-complications-respiratory-syncitial-virus-infants.html","snippet":"NACI literature review on the effects of palivizumab prophylaxis on reducing the complications associated with respiratory syncytial virus in infants - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search…","rawSnapshotUrl":"/api/snapshots/raw/153528","browseUrl":"https://replay.healtharchive.ca/job-1/20250418122046/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/effects-palivizumab-prophylaxis-reducing-complications-respiratory-syncitial-virus-infants.html#ha_snapshot=153528","mimeType":"text/html","statusCode":200}